Evidence map›Paper›PMID 39973220›Full record

Observational studyAIDS patient care and STDs2025

Exploring Stigma and Self-Image: Mixed-Methods Insights from HIV Cure-Related Research Participants Undergoing Analytical Treatment Interruptions.

Steven Meanley, Lidia Rodriguez Garcia, Nadra E Lisha, Ali Ahmed, Anastasia Korolkova, Tony Figueroa, Elizabeth Nguyen, Michael J Peluso, Lillian B Cohn, Steven Deeks and 2 more

2 registry-linked trialsAbstract readObservational Study
In one paragraph

Observational study in AIDS patient care and STDs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00187512 recruitingnot on this map

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

TypeobservationalSponsorUniversity of California, San FranciscoRan2000 to 2033Enrolled2,500ConditionsHIV Infections
NCT04359186 narecruitingnot on this map

Analytic Treatment Interruption in HIV Infection

TypeinterventionalSponsorUniversity of California, San FranciscoRan2020 to 2028Enrolled40ConditionsHIV/AIDSArmsTreatment Interruption Arm
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Steven MeanleyDepartment of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-6098-9733
Lidia Rodriguez GarciaDivision of Prevention Science, School of Medicine, University of California at San Francisco,San Francisco, California, USA.
Nadra E LishaDivision of Prevention Science, School of Medicine, University of California at San Francisco,San Francisco, California, USA.
Ali AhmedDivision of Infectious Diseases and Global Public Health, School of Medicine, University of California at San Diego, San Diego, California, USA.
Anastasia KorolkovaDivision of Infectious Diseases and Global Public Health, School of Medicine, University of California at San Diego, San Diego, California, USA.
Tony FigueroaDivision of HIV, Infectious Diseases and Global Medicine, School of Medicine, University of California at San Francisco, San Francisco, California, USA.
Elizabeth NguyenDivision of Infectious Diseases and Global Public Health, School of Medicine, University of California at San Diego, San Diego, California, USA.
Michael J PelusoDivision of Prevention Science, School of Medicine, University of California at San Francisco,San Francisco, California, USA.
Lillian B CohnFred Hutchinson Cancer Center, Seattle, Washington, USA.
Steven DeeksDivision of HIV, Infectious Diseases and Global Medicine, School of Medicine, University of California at San Francisco, San Francisco, California, USA.
Karine DubéDivision of Prevention Science, School of Medicine, University of California at San Francisco,San Francisco, California, USA.
John SaucedaDivision of Infectious Diseases and Global Public Health, School of Medicine, University of California at San Diego, San Diego, California, USA.

Funding

First-in-human study of two anti-SARS CoV-2 antibodies in health volunteersUM1AI126620 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J, RILEY, JAMES L. · 2016 to 2021
$24.5M
Penn Mental Health AIDS Research CenterP30MH097488 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Karine Dube, Kelly L Jordan-Sciutto · 2013 to 2026
$23.5M
Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical ConductR01MH126768 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUBE, KARINE, SAUCEDA, JOHN ANDREW · 2021 to 2025
$3.6M
NIAID NIH HHS UM1 AI126620NIMH NIH HHS P30 MH097488NIMH NIH HHS R01 MH126768
6 · The paper itself

Abstract

This mixed-methods study explored self-image among people with HIV participating in an HIV cure-related study involving analytical treatment interruptions (ATIs). Using both quantitative and qualitative approaches, we described how self-image emerged across study participation, focusing on internalized stigma, emotional strengths, and the psychosocial dimensions of study participation. Data come from the SCOPE-ATI substudy (NCT00187512) of the University of California San Francisco SCOPE cohort (NCT04359186). Quantitative data were collected at three timepoints: pre-ATI (

Indexed as

Anti-HIV AgentsHIV InfectionsSelf ConceptSocial StigmaAdultFemaleHumansInterviews as TopicMaleMiddle AgedQualitative ResearchSan FranciscoAnti-HIV Agentsanalytical treatment interruptionsHIV cure researchself-imagestigma

Identifiers

PMID39973220
PMCPMC12139701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.